Incorporating utility-based quality-of-life assessment measures in clinical trials

Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/17082

Full metadata record

DC Field	Value	Language
dc.contributor.author	Feeny, David	en_US
dc.contributor.author	Torrance, George W.	en_US
dc.contributor.author	Centre for Health Economics and Policy Analysis	en_US
dc.date.accessioned	2015-04-14T14:42:01Z	-
dc.date.available	2015-04-14T14:42:01Z	-
dc.date.issued	1989	en_US
dc.identifier.uri	http://hdl.handle.net/11375/17082	-
dc.description	David Feeny, George W. Torrance.	en_US
dc.description	Bibliography: leaves 22-25.	en_US
dc.format.extent	25 leaves.	en_US
dc.publisher	Centre for Health Economics and Policy Analysis]	en_US
dc.relation.ispartofseries	CHEPA working paper series no. 12	en_US
dc.subject	Economics, Medical	en_US
dc.subject	Value of Life	en_US
dc.subject	Quality of Life	en_US
dc.subject	Physicians	en_US
dc.subject	supply & distribution	en_US
dc.subject	Clinical Trials as Topic	en_US
dc.subject	methods	en_US
dc.subject	Outcome and Process Assessment (Health Care)	en_US
dc.subject	methods	en_US
dc.title	Incorporating utility-based quality-of-life assessment measures in clinical trials	en_US
dc.type	text	en_US
Appears in Collections:	CHEPA Working Paper Series

Files in This Item:

There are no files associated with this item.